Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-and-Forest-Announce-US-Availability-of-LINZESS-Linaclotide/default.aspx
Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-and-Forest-Announce-US-Availability-of-LINZESS-Linaclotide/default.aspx
Protagonist and Ironwood Expand Peptide Drug Discovery Collaboration
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Protagonist-and-Ironwood-Expand-Peptide-Drug-Discovery-Collaboration/default.aspx
Protagonist and Ironwood Expand Peptide Drug Discovery Collaboration
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Protagonist-and-Ironwood-Expand-Peptide-Drug-Discovery-Collaboration/default.aspx
Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Constella-linaclotide-Approved-in-Europe-for-the-Treatment-of-Irritable-Bowel-Syndrome-with-Constipation-IBS-C-in-Adults/default.aspx
Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Constella-linaclotide-Approved-in-Europe-for-the-Treatment-of-Irritable-Bowel-Syndrome-with-Constipation-IBS-C-in-Adults/default.aspx
Ironwood Pharmaceuticals to Present at the Credit Suisse 2012 Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-Pharmaceuticals-to-Present-at-the-Credit-Suisse-2012-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals to Present at the Credit Suisse 2012 Healthcare Conference
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-Pharmaceuticals-to-Present-at-the-Credit-Suisse-2012-Healthcare-Conference/default.aspx
Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-Pharmaceuticals-to-Host-Webinar-on-Accounting-Treatment-for-LINZESS-Linaclotide/default.aspx
Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)
https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-Pharmaceuticals-to-Host-Webinar-on-Accounting-Treatment-for-LINZESS-Linaclotide/default.aspx